APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Whole Cell Cholera Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Whole Cell Cholera Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174047620319 December 2025193 pages

Choose your research edition.

Industry ResearchWhole Cell Cholera Vaccine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Whole Cell Cholera Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Whole Cell Cholera Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Whole Cell Cholera Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Whole Cell Cholera Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Whole Cell Cholera Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Whole Cell Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Whole Cell Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Whole Cell Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Whole Cell Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Whole Cell Cholera Vaccine include Johnson and Johnson, Merck, Pfizer, GlaxoSmithKline, Valneva SE, Serum Institute of India, SBL Vaccine, Sanofi Pasteur and PaxVax, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Whole Cell Cholera Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Whole Cell Cholera Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Whole Cell Cholera Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Whole Cell Cholera Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Whole Cell Cholera Vaccine Segment by Company

Johnson and Johnson

Merck

Pfizer

GlaxoSmithKline

Valneva SE

Serum Institute of India

SBL Vaccine

Sanofi Pasteur

PaxVax

AstraZeneca(Medimmune, LLC.)

Whole Cell Cholera Vaccine Segment by Type

For Adults

For Children

Whole Cell Cholera Vaccine Segment by Application

Hospital

Surgical Centers

Clinical Research Institutes

Others

Whole Cell Cholera Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Cell Cholera Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Whole Cell Cholera Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Cell Cholera Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Whole Cell Cholera Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Whole Cell Cholera Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Whole Cell Cholera Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Whole Cell Cholera Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Whole Cell Cholera Vaccine Industry Trends Table 2. Whole Cell Cholera Vaccine Industry Drivers Table 3. Whole Cell Cholera Vaccine Industry Opportunities and Challenges Table 4. Whole Cell Cholera Vaccine Industry Restraints Table 5. Global Whole Cell Cholera Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Whole Cell Cholera Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Whole Cell Cholera Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Whole Cell Cholera Vaccine Sales Market Share by Manufacturers Table 9. Global Whole Cell Cholera Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Whole Cell Cholera Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Whole Cell Cholera Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Whole Cell Cholera Vaccine Manufacturers, Product Type & Application Table 13. Global Whole Cell Cholera Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Whole Cell Cholera Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of For Adults Table 17. Major Manufacturers of For Children Table 18. Global Whole Cell Cholera Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Whole Cell Cholera Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Whole Cell Cholera Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Whole Cell Cholera Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Whole Cell Cholera Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Whole Cell Cholera Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Surgical Centers Table 30. Major Manufacturers of Clinical Research Institutes Table 31. Major Manufacturers of Others Table 32. Global Whole Cell Cholera Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Whole Cell Cholera Vaccine Sales by Application (2021-2026) & (K Units) Table 34. Global Whole Cell Cholera Vaccine Sales by Application (2027-2032) & (K Units) Table 35. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Whole Cell Cholera Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Whole Cell Cholera Vaccine Revenue by Application (2021-2026) & (K Units) Table 39. Global Whole Cell Cholera Vaccine Revenue by Application (2027-2032) & (K Units) Table 40. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Whole Cell Cholera Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Whole Cell Cholera Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Whole Cell Cholera Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Whole Cell Cholera Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Whole Cell Cholera Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Whole Cell Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Whole Cell Cholera Vaccine Sales by Country (2021-2026) & (K Units) Table 49. North America Whole Cell Cholera Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Whole Cell Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Whole Cell Cholera Vaccine Sales by Country (2021-2026) & (K Units) Table 52. Europe Whole Cell Cholera Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Whole Cell Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Whole Cell Cholera Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Whole Cell Cholera Vaccine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Whole Cell Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Whole Cell Cholera Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Whole Cell Cholera Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Whole Cell Cholera Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2027-2032) Table 64. Johnson and Johnson Company Information Table 65. Johnson and Johnson Business Overview Table 66. Johnson and Johnson Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Johnson and Johnson Whole Cell Cholera Vaccine Product Portfolio Table 68. Johnson and Johnson Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck Whole Cell Cholera Vaccine Product Portfolio Table 73. Merck Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Whole Cell Cholera Vaccine Product Portfolio Table 78. Pfizer Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Whole Cell Cholera Vaccine Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. Valneva SE Company Information Table 85. Valneva SE Business Overview Table 86. Valneva SE Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Valneva SE Whole Cell Cholera Vaccine Product Portfolio Table 88. Valneva SE Recent Development Table 89. Serum Institute of India Company Information Table 90. Serum Institute of India Business Overview Table 91. Serum Institute of India Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Serum Institute of India Whole Cell Cholera Vaccine Product Portfolio Table 93. Serum Institute of India Recent Development Table 94. SBL Vaccine Company Information Table 95. SBL Vaccine Business Overview Table 96. SBL Vaccine Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. SBL Vaccine Whole Cell Cholera Vaccine Product Portfolio Table 98. SBL Vaccine Recent Development Table 99. Sanofi Pasteur Company Information Table 100. Sanofi Pasteur Business Overview Table 101. Sanofi Pasteur Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Sanofi Pasteur Whole Cell Cholera Vaccine Product Portfolio Table 103. Sanofi Pasteur Recent Development Table 104. PaxVax Company Information Table 105. PaxVax Business Overview Table 106. PaxVax Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. PaxVax Whole Cell Cholera Vaccine Product Portfolio Table 108. PaxVax Recent Development Table 109. AstraZeneca(Medimmune, LLC.) Company Information Table 110. AstraZeneca(Medimmune, LLC.) Business Overview Table 111. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product Portfolio Table 113. AstraZeneca(Medimmune, LLC.) Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Whole Cell Cholera Vaccine Distributors List Table 117. Whole Cell Cholera Vaccine Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Whole Cell Cholera Vaccine Product Image Figure 2. Global Whole Cell Cholera Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Whole Cell Cholera Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Whole Cell Cholera Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Whole Cell Cholera Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Whole Cell Cholera Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. For Adults Image Figure 9. For Children Image Figure 10. Global Whole Cell Cholera Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Whole Cell Cholera Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Whole Cell Cholera Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Whole Cell Cholera Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Surgical Centers Image Figure 18. Clinical Research Institutes Image Figure 19. Others Image Figure 20. Global Whole Cell Cholera Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Whole Cell Cholera Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Whole Cell Cholera Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Whole Cell Cholera Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Whole Cell Cholera Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Whole Cell Cholera Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Whole Cell Cholera Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Whole Cell Cholera Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Whole Cell Cholera Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Whole Cell Cholera Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Whole Cell Cholera Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Whole Cell Cholera Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Whole Cell Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Whole Cell Cholera Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Whole Cell Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Whole Cell Cholera Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Whole Cell Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Whole Cell Cholera Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Whole Cell Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Whole Cell Cholera Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Whole Cell Cholera Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • For Adults
  • For Children
Applications
  • Hospital
  • Surgical Centers
  • Clinical Research Institutes
  • Others
Companies covered
  • Johnson and Johnson
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Valneva SE
  • Serum Institute of India
  • SBL Vaccine
  • Sanofi Pasteur
  • PaxVax
  • AstraZeneca(Medimmune, LLC.)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Whole Cell Cholera Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Whole Cell Cholera Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Whole Cell Cholera Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Whole Cell Cholera Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Whole Cell Cholera Vaccine Market Dynamics
  1. 2.1 Whole Cell Cholera Vaccine Industry Trends
  2. 2.2 Whole Cell Cholera Vaccine Industry Drivers
  3. 2.3 Whole Cell Cholera Vaccine Industry Opportunities and Challenges
  4. 2.4 Whole Cell Cholera Vaccine Industry Restraints
3 Whole Cell Cholera Vaccine Market by Manufacturers
  1. 3.1 Global Whole Cell Cholera Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Whole Cell Cholera Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Whole Cell Cholera Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Whole Cell Cholera Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Whole Cell Cholera Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Whole Cell Cholera Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Whole Cell Cholera Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Whole Cell Cholera Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Whole Cell Cholera Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Whole Cell Cholera Vaccine Tier 1, Tier 2, and Tier 3
4 Whole Cell Cholera Vaccine Market by Type
  1. 4.1 Whole Cell Cholera Vaccine Type Introduction
  2. 4.1.1 For Adults
  3. 4.1.2 For Children
  4. 4.2 Global Whole Cell Cholera Vaccine Sales by Type
  5. 4.2.1 Global Whole Cell Cholera Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Whole Cell Cholera Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Whole Cell Cholera Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Whole Cell Cholera Vaccine Revenue by Type
  9. 4.3.1 Global Whole Cell Cholera Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Whole Cell Cholera Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2021-2032)
5 Whole Cell Cholera Vaccine Market by Application
  1. 5.1 Whole Cell Cholera Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Surgical Centers
  4. 5.1.3 Clinical Research Institutes
  5. 5.1.4 Others
  6. 5.2 Global Whole Cell Cholera Vaccine Sales by Application
  7. 5.2.1 Global Whole Cell Cholera Vaccine Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Whole Cell Cholera Vaccine Sales by Application (2021-2032)
  9. 5.2.3 Global Whole Cell Cholera Vaccine Sales Market Share by Application (2021-2032)
  10. 5.3 Global Whole Cell Cholera Vaccine Revenue by Application
  11. 5.3.1 Global Whole Cell Cholera Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Whole Cell Cholera Vaccine Revenue by Application (2021-2032)
  13. 5.3.3 Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2021-2032)
6 Global Whole Cell Cholera Vaccine Sales by Region
  1. 6.1 Global Whole Cell Cholera Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Whole Cell Cholera Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Whole Cell Cholera Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Whole Cell Cholera Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Whole Cell Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Whole Cell Cholera Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Whole Cell Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Whole Cell Cholera Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Whole Cell Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Whole Cell Cholera Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Whole Cell Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Whole Cell Cholera Vaccine Revenue by Region
  1. 7.1 Global Whole Cell Cholera Vaccine Revenue by Region
  2. 7.1.1 Global Whole Cell Cholera Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Whole Cell Cholera Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Whole Cell Cholera Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Whole Cell Cholera Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Whole Cell Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Whole Cell Cholera Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Whole Cell Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Whole Cell Cholera Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Whole Cell Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Whole Cell Cholera Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Whole Cell Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson and Johnson
  2. 8.1.1 Johnson and Johnson Company Information
  3. 8.1.2 Johnson and Johnson Business Overview
  4. 8.1.3 Johnson and Johnson Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson and Johnson Whole Cell Cholera Vaccine Product Portfolio
  6. 8.1.5 Johnson and Johnson Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Whole Cell Cholera Vaccine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Whole Cell Cholera Vaccine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Whole Cell Cholera Vaccine Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Valneva SE
  26. 8.5.1 Valneva SE Company Information
  27. 8.5.2 Valneva SE Business Overview
  28. 8.5.3 Valneva SE Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Valneva SE Whole Cell Cholera Vaccine Product Portfolio
  30. 8.5.5 Valneva SE Recent Developments
  31. 8.6 Serum Institute of India
  32. 8.6.1 Serum Institute of India Company Information
  33. 8.6.2 Serum Institute of India Business Overview
  34. 8.6.3 Serum Institute of India Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Serum Institute of India Whole Cell Cholera Vaccine Product Portfolio
  36. 8.6.5 Serum Institute of India Recent Developments
  37. 8.7 SBL Vaccine
  38. 8.7.1 SBL Vaccine Company Information
  39. 8.7.2 SBL Vaccine Business Overview
  40. 8.7.3 SBL Vaccine Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SBL Vaccine Whole Cell Cholera Vaccine Product Portfolio
  42. 8.7.5 SBL Vaccine Recent Developments
  43. 8.8 Sanofi Pasteur
  44. 8.8.1 Sanofi Pasteur Company Information
  45. 8.8.2 Sanofi Pasteur Business Overview
  46. 8.8.3 Sanofi Pasteur Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Pasteur Whole Cell Cholera Vaccine Product Portfolio
  48. 8.8.5 Sanofi Pasteur Recent Developments
  49. 8.9 PaxVax
  50. 8.9.1 PaxVax Company Information
  51. 8.9.2 PaxVax Business Overview
  52. 8.9.3 PaxVax Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PaxVax Whole Cell Cholera Vaccine Product Portfolio
  54. 8.9.5 PaxVax Recent Developments
  55. 8.10 AstraZeneca(Medimmune, LLC.)
  56. 8.10.1 AstraZeneca(Medimmune, LLC.) Company Information
  57. 8.10.2 AstraZeneca(Medimmune, LLC.) Business Overview
  58. 8.10.3 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product Portfolio
  60. 8.10.5 AstraZeneca(Medimmune, LLC.) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Whole Cell Cholera Vaccine Value Chain Analysis
  2. 9.1.1 Whole Cell Cholera Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Whole Cell Cholera Vaccine Production Mode & Process
  6. 9.2 Whole Cell Cholera Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Whole Cell Cholera Vaccine Distributors
  9. 9.2.3 Whole Cell Cholera Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst